When did CG Oncology report Q4 2024 earnings?

CG Oncology (CGON) reported Q4 2024 earnings on March 28, 2025 before market open.

What were CG Oncology's Q4 2024 revenue and EPS?

CG Oncology reported revenue of $456.0K and eps of $-0.48 for Q4 2024.

Did CG Oncology beat estimates in Q4 2024?

Revenue beat the consensus estimate of $124.0K by $332.1K. EPS missed the consensus estimate of $-0.41 by $0.07.

Where can I find CG Oncology's Q4 2024 SEC filings?

You can read the 10-K periodic report (0000950170-25-046351) directly on SEC EDGAR. The filing index links above go to sec.gov.

CG Oncology CGON Q4 2024 Annual earnings

Reported March 28, 2025 · Before market open

Revenue$456.0KBeat by $332.1K

EPS-$0.48Miss by $0.07

Revenue estimate$124.0K

EPS estimate-$0.41

Next report

Aug 7, 2026 (In 1 week)

Revenue estimate$360.8K

EPS estimate-$0.70

Financials

Q4 2024

Income statement

See full

Revenue$456.0K+45,500%

Operating income-$38.0M-96.6%

Net income-$31.8M-92.1%

EPS (diluted)-$0.48+89.3%

Balance sheet

See full

Cash & equivalents$257.1M+3,010%

Total debt$238.0K-48.4%

Total equity$733.4M+696%

Total assets$754.8M+279%

Cash flow

See full

Operating cash flow-$20.7M-41.1%

CapEx$209.0K—

Free cash flow-$20.9M—

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$2.18B—

Enterprise value$1.93B—

P/S1,916.9×—

Profitability

See full

Operating margin-10,067.3%-3,889pp

Net margin-7,729.5%-3,117pp

FCF margin-6,931.3%—

Returns & leverage

See full

Debt / equity0×—

Current ratio35.3×+21.7×

Segments

By product

See full

License And Collaboration Revenue$456.0K+794%

Commercial And Development Revenue-—

Versus estimates

Revenue

Q1 2026$1.1MBeat by $630.0K Q4 2025$2.3MBeat by $1.8M Q3 2025$1.7MBeat by $1.6M Q1 2025$52.0KMiss by $66.2K

Q4 2024$456.0KBeat by $332.1K

Diluted EPS

Q1 2026-$0.71Miss by $0.13 Q4 2025-$0.51Beat by $0.10 Q3 2025-$0.57Miss by $0.01 Q2 2025-$0.54Miss by $0.05 Q1 2025-$0.45Miss by $0.06

Q4 2024-$0.48Miss by $0.07

Ask the moment CG Oncology reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did CG Oncology report Q4 2024 earnings?: CG Oncology (CGON) reported Q4 2024 earnings on March 28, 2025 before market open.
What were CG Oncology's Q4 2024 revenue and EPS?: CG Oncology reported revenue of $456.0K and eps of $-0.48 for Q4 2024.
Did CG Oncology beat estimates in Q4 2024?: Revenue beat the consensus estimate of $124.0K by $332.1K. EPS missed the consensus estimate of $-0.41 by $0.07.
Where can I find CG Oncology's Q4 2024 SEC filings?: You can read the 10-K periodic report (0000950170-25-046351) directly on SEC EDGAR. The filing index links above go to sec.gov.